NERV

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Minerva Neurosciences (NERV) Earnings Date & Reports

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NERV is expected to report earnings to rise 91.07% to -107 cents per share on May 13

Minerva Neurosciences NERV Stock Earnings Reports

Q1'25

Est.

$-1.07

Q4'24

Missed

by $1.53

Q3'24

Beat

by $3.98

Q2'24

Missed

by $0.12

Q1'24

Missed

by $0.12

The last earnings report on February 25 showed earnings per share of -56 cents, missing the estimate of 97 cents. With 3.90K shares outstanding, the current market capitalization sits at 12.24M.

View a ticker or compare two or three

Compare

NERV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NERV
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1500 District Avenue

Phone

+1 617 600-7373

Employees

Web

https://www.minervaneurosciences.com